10x Genomics Inc. Class A Common Stock (TXG)
NASDAQ
Closed
Oct 8, 2026
Day's Range
70.9452 wk Range
11.16Overview - TXG - 10x Genomics Inc. Class A Common Stock
Key Statistics
Valuation
Enterprise Value
11.09B
P/E (Trailing)
‪-267.14‬
P/E (Forward)
‪1,157.68‬
PEG Ratio
‪1.78‬
Price / Sales (TTM)
‪18.74‬
Price / Book
‪14.00‬
EV / EBITDA
‪-269.20‬
Profitability
Gross Margin
‪74.48%‬
Profit Margin
‪-12.17%‬
Operating Margin
‪-15.19%‬
Return on Assets
‪-5.04%‬
Return on Equity
‪-9.39%‬
Ownership
Shares Outstanding
130.28M
Float
118.19M
Short % of Shares Outstanding
‪18.79%‬
Held by Insiders
‪1.46%‬
Held by Institutions
‪120.27%‬
Price stats
Beta
‪2.07‬
50-Day Avg
‪63.06‬
200-Day Avg
‪33.99‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
19 analysts
Average price target
‪$ 49.54‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - TXG - 10x Genomics Inc. Class A Common Stock
Peers - TXG - 10x Genomics Inc. Class A Common Stock
Peer Comparison
Compared with companies in Health Information Services listed on NASDAQ.
Profile Summary - TXG - 10x Genomics Inc. Class A Common Stock
About
10x Genomics Inc. Class A Common Stock represents ownership in 10x Genomics, a life science technology company focused on products that help researchers study biology at high resolution. The company develops integrated instruments, consumables, and software used for single-cell and spatial biology workflows,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
